Kina - kinesisk - CFDA (药监局 - 中国食品和药物管理局)

开开援生制药股份有限公司 - 片剂(糖衣) - 0.15g

Singapore - engelsk - HSA (Health Sciences Authority)

qt instruments (s) pte ltd - general hospital - the iradimed corporation’s 3880 mri patient monitoring system is intended to monitor a single patient’s vital signs for patients undergoing magnetic resonance imaging (mri) procedures. the 3880 mri patient monitoring system is intended for use by healthcare professionals. the 3880 mri patient monitoring system is intended for use in adult and pediatric, including neonatal populations, for monitoring of electrocardiogram (ecg), non-invasive blood pressure (nibp), invasive blood pressure (ibp), pulse oximetry (spo2), temperature, anesthetic agents, respiration, capnography (co2), and oxygen (o2).

USA - engelsk - NLM (National Library of Medicine)

directrx - tizanidine hydrochloride (unii: b53e3nmy5c) (tizanidine - unii:6ai06c00gw) - tizanidine is a central alpha-2-adrenergic agonist indicated for the management of spasticity. because of the short duration of therapeutic effect, treatment with tizanidine should be reserved for those daily activities and times when relief of spasticity is most important [see dosage and administration (2.1)]. tizanidine is contraindicated in patients taking potent inhibitors of cyp1a2, such as fluvoxamine or ciprofloxacin [see drug interactions (7.1, 7.2)]. 8.1 pregnancy pregnancy category c tizanidine has not been studied in pregnant women. tizanidine should be given to pregnant women only if the benefit outweighs the risk to the unborn fetus. reproduction studies performed in rats at a dose of 3 mg/kg, equal to the maximum recommended human dose on a mg/m2 basis, and in rabbits at 30 mg/kg, 16 times the maximum recommended human dose on a mg/m2 basis, did not show evidence of teratogenicity. tizanidine at doses that are equal to and up to 8 times the maximum recommended human dose on a mg/m2 basis increas

USA - engelsk - NLM (National Library of Medicine)

direct_rx - tizanidine hydrochloride (unii: b53e3nmy5c) (tizanidine - unii:6ai06c00gw) - tizanidine is a central alpha-2-adrenergic agonist indicated for the management of spasticity. because of the short duration of therapeutic effect, treatment with tizanidine should be reserved for those daily activities and times when relief of spasticity is most important [see dosage and administration (2.1)]. tizanidine is contraindicated in patients taking potent inhibitors of cyp1a2, such as fluvoxamine or ciprofloxacin [see drug interactions (7.1, 7.2)]. 8.1 pregnancy pregnancy category c tizanidine has not been studied in pregnant women. tizanidine should be given to pregnant women only if the benefit outweighs the risk to the unborn fetus. reproduction studies performed in rats at a dose of 3 mg/kg, equal to the maximum recommended human dose on a mg/m2 basis, and in rabbits at 30 mg/kg, 16 times the maximum recommended human dose on a mg/m2 basis, did not show evidence of teratogenicity. tizanidine at doses that are equal to and up to 8 times the maximum recommended human dose on a mg/m2 basis increas

USA - engelsk - NLM (National Library of Medicine)

direct_rx - tizanidine hydrochloride (unii: b53e3nmy5c) (tizanidine - unii:6ai06c00gw) - tizanidine is a central alpha-2-adrenergic agonist indicated for the management of spasticity. because of the short duration of therapeutic effect, treatment with tizanidine should be reserved for those daily activities and times when relief of spasticity is most important [see dosage and administration (2.1)]. tizanidine is contraindicated in patients taking potent inhibitors of cyp1a2, such as fluvoxamine or ciprofloxacin [see drug interactions (7.1, 7.2)]. 8.1 pregnancy pregnancy category c tizanidine has not been studied in pregnant women. tizanidine should be given to pregnant women only if the benefit outweighs the risk to the unborn fetus. reproduction studies performed in rats at a dose of 3 mg/kg, equal to the maximum recommended human dose on a mg/m2 basis, and in rabbits at 30 mg/kg, 16 times the maximum recommended human dose on a mg/m2 basis, did not show evidence of teratogenicity. tizanidine at doses that are equal to and up to 8 times the maximum recommended human dose on a mg/m2 basis increas

USA - engelsk - NLM (National Library of Medicine)

direct_rx - tizanidine hydrochloride (unii: b53e3nmy5c) (tizanidine - unii:6ai06c00gw) - tizanidine is a central alpha-2-adrenergic agonist indicated for the management of spasticity. because of the short duration of therapeutic effect, treatment with tizanidine should be reserved for those daily activities and times when relief of spasticity is most important [see dosage and administration (2.1)]. tizanidine is contraindicated in patients taking potent inhibitors of cyp1a2, such as fluvoxamine or ciprofloxacin [see drug interactions (7.1, 7.2)]. 8.1 pregnancy pregnancy category c tizanidine has not been studied in pregnant women. tizanidine should be given to pregnant women only if the benefit outweighs the risk to the unborn fetus. reproduction studies performed in rats at a dose of 3 mg/kg, equal to the maximum recommended human dose on a mg/m2 basis, and in rabbits at 30 mg/kg, 16 times the maximum recommended human dose on a mg/m2 basis, did not show evidence of teratogenicity. tizanidine at doses that are equal to and up to 8 times the maximum recommended human dose on a mg/m2 basis increas

USA - engelsk - NLM (National Library of Medicine)

direct rx - tizanidine hydrochloride (unii: b53e3nmy5c) (tizanidine - unii:6ai06c00gw) - tizanidine is a central alpha-2-adrenergic agonist indicated for the management of spasticity. because of the short duration of therapeutic effect, treatment with tizanidine should be reserved for those daily activities and times when relief of spasticity is most important [see dosage and administration (2.1)]. tizanidine is contraindicated in patients taking potent inhibitors of cyp1a2, such as fluvoxamine or ciprofloxacin [see drug interactions (7.1, 7.2)]. 8.1 pregnancy pregnancy category c tizanidine has not been studied in pregnant women. tizanidine should be given to pregnant women only if the benefit outweighs the risk to the unborn fetus. reproduction studies performed in rats at a dose of 3 mg/kg, equal to the maximum recommended human dose on a mg/m2 basis, and in rabbits at 30 mg/kg, 16 times the maximum recommended human dose on a mg/m2 basis, did not show evidence of teratogenicity. tizanidine at doses that are equal to and up to 8 times the maximum recommended human dose on a mg/m2 basis increas

Singapore - engelsk - HSA (Health Sciences Authority)

qt instruments (s) pte ltd - general hospital - the iradimed corporation's mridium 3860 mri infusion pump/monitoring system is intended for general hospital or clinical use by medical professionals whenever it is required to infuse patients with subcutaneous, intra-venous or intra-arterial fluids before, during, or after magnetic resonance imaging (mri) scans, functioning while either in a stationary or mobile position.

Italia - italiensk - AIFA (Agenzia Italiana del Farmaco)

lanova farmaceutici s.r.l. - granisetron - granisetron

Canada - fransk - Health Canada

pendopharm division of pharmascience inc - acide acétylsalicylique - comprimé (à libération retardée) - 325mg - acide acétylsalicylique 325mg - salicylates